ストックスクリーナーアプリを入手
0.7074
3.13%
0.0215
前日終値:
$0.6859
開ける：
$0.7
24時間の取引高:
29,910
Relative Volume:
0.04
時価総額：
$1.60M
収益：
$71.39M
当期純損益:
$-28.60M
株価収益率:
-0.1891
EPS:
-3.74
ネットキャッシュフロー:
$-12.92M
1週間 パフォーマンス:
+5.50%
1か月 パフォーマンス:
+1.31%
6か月 パフォーマンス:
-21.41%
1年 パフォーマンス:
-75.14%
1日の値動き範囲:
$0.70
$0.72
1週間の範囲:
$0.64
$0.72
52週間の値動き範囲:
$0.48
$3.39
Trinity Biotech Plc Adr Stock (TRIB) Company Profile
TRIB を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TRIB
Trinity Biotech Plc Adr
|
0.7074 | 12.67M | 71.39M | -28.60M | -12.92M | -3.74 |
|
ABT
Abbott Laboratories
|
127.31 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.70 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
378.38 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
88.91 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.69 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Trinity Biotech Plc Adr Stock (TRIB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2015-10-23 | ダウングレード | Craig Hallum | Buy → Hold |
| 2015-09-03 | 開始されました | Raymond James | Outperform |
| 2015-07-29 | 繰り返されました | ROTH Capital | Buy |
| 2008-07-22 | 繰り返されました | Roth Capital | Buy |
| 2008-03-17 | 繰り返されました | Roth Capital | Buy |
| 2007-12-10 | 繰り返されました | Roth Capital | Buy |
| 2007-10-26 | 繰り返されました | Roth Capital | Buy |
すべてを表示
Trinity Biotech Plc Adr (TRIB) 最新ニュース
Cadence Bank (CADE) Stock: A Year of Market Fluctuations - investchronicle.com
Trinity Biotech receives WHO approval for offshore HIV test manufacturing - Investing.com
Trinity Biotech Appoints New Interim CFO - Investing.com India
Trinity Biotech stock hits 52-week low at $0.62 amid challenges - Investing.com
Trinity Biotech (NASDAQ:TRIB) Research Coverage Started at StockNews.com - Armenian Reporter
Trinity Biotech stock hits 52-week low at $0.72 amid challenges By Investing.com - Investing.com South Africa
Trinity Biotech stock hits 52-week low at $0.72 amid challenges - Investing.com
Trinity Biotech secures amended credit to fuel growth By Investing.com - Investing.com South Africa
Trinity Biotech secures amended credit to fuel growth - Investing.com India
Trinity Biotech secures $4m for CGM technology growth - Investing.com
Investor Network: Trinity Biotech Plc Sponsored ADR to Host Earnings Call - ACCESS Newswire
TRIBTrinity Biotech Announces Quarter 1 Financial Results - br.ADVFN.com
Trinity Biotech Announces Quarter 2 Results Revenues of US$36.3m and Operating Profit of US$2.3m - br.ADVFN.com
Trinity Biotech Announces Quarter 4 Financial Results EPS of 17.1 Cent per Share -- an Increase of 10.3% - br.ADVFN.com
Trinity Biotech Announces Quarter 3 Results; Revenues Increase to $35.6m; Operating Profit Increases 56% - br.ADVFN.com
Trinity Biotech stock hits 52-week low at $0.74 amid market challenges - Investing.com
Trinity Biotech Announces Quarter 3 Financial Results, Acquisition of Blood Bank Screening Business and FDA Approval of HIV-2... - br.ADVFN.com
Trinity Biotech Plc ADR (TRIB) Stock: A Year of Market Movement, Down and Up - The InvestChronicle
Market Highlights: Xometry Inc (XMTR) Ends on a Low Note at 36.21 - The Dwinnex
Daily Progress: SiTime Corp (SITM) Drop -20.93, Closing at 176.32 - The Dwinnex
Trinity Biotech Plc ADR (TRIB) Shares Down Despite Recent Market Volatility - The News Heater
Trinity Biotech reports leap in CGM system accuracy - Investing.com
Trinity Biotech secures US funding for HIV tests - Investing.com
Trinity Biotech faces US aid policy impact, PPP loan scrutiny - Investing.com
Trinity Biotech announces breakthrough in CGM technology - Investing.com
Trinity Biotech stock hits 52-week low at $0.74 amid challenges By Investing.com - Investing.com South Africa
Trinity Biotech advances HIV test manufacturing to offshore site - Investing.com
Trinity Biotech regains Nasdaq compliance - Investing.com
Trinity Biotech expands into oncology with EpiCapture buyout - Investing.com
Trinity Biotech advances next-gen glucose monitor - Investing.com India
North America Blood Testing Market Size & Outlook, 2030 - Grand View Research
Middle East & Africa Blood Testing Market Size & Outlook, 2030 - Grand View Research
India Blood Testing Market Size & Outlook, 2023-2030 - Grand View Research
Germany Blood Testing Market Size & Outlook, 2023-2030 - Grand View Research
Global Blood Testing Market Size & Outlook, 2024-2030 - Grand View Research
UK Blood Testing Market Size & Outlook, 2023-2030 - Grand View Research
Trinity Biotech to Implement ADS Ratio Change By Investing.com - Investing.com India
The Daily Biotech Pulse: IPOs, Puma's Breast Cancer Drug Gets Label Expansion, Buyout Offer For Organovo - Yahoo Finance
TRIB News Today | Why did Trinity Biotech stock go up today? - MarketBeat
Press Release Distribution & PR Platform - ACCESS Newswire
Investors in health-care stocks get rich as M&A booms - MarketWatch
Why Synta Pharmaceuticals Corp. (SNTA) May Be Worth Selling - Insider Monkey
Trinity Biotech Plc Adr (TRIB) 財務データ
収益
当期純利益
現金流量
EPS
0.93%
1.26%
大文字化:
|
ボリューム (24 時間):